UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004563
Receipt No. R000005452
Scientific Title A phase II study of Erlotinib for patients previously treated non-small cell lung cancer with epidermal growth factor receptor mutation
Date of disclosure of the study information 2010/11/15
Last modified on 2018/11/24 21:35:17

No. Disposal Last modified on Item of update
1 Insert 2010/11/15 22:24:42
2 Update 2012/12/10 22:13:31 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2018/11/24 21:34:38 Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Address
Address
Email
Name of primary sponsor
Institute
Organization
4 Update 2018/11/24 21:35:17 Recruitment status


Contact us.